EAF:NYSEGrafTech International Ltd. Analysis
Data as of 2026-06-22 - not real-time
$7.73
Latest Price
8/10Risk
Risk Level: High
Executive Summary
GrafTech’s share price is hovering just above a key support level while technical momentum remains bearish, as evidenced by a negative MACD and a neutral‑to‑slightly‑oversold RSI. The stock trades with exceptionally high volatility and a beta that signals outsized moves relative to the market, compounded by a sharp decline in trading volume, which together suggest a fragile price environment. Fundamentally, the company shows solid top‑line growth but continues to generate negative margins, heavy debt, and cash‑flow deficits, although the latest earnings beat and rising analyst price targets hint at a modest upside narrative. The market sentiment is currently in a phase of extreme greed, which may be inflating short‑term expectations despite the underlying financial strain.
Given the low price‑to‑sales multiple and the absence of dividend payments, the valuation appears discounted relative to peers, yet the balance sheet weakness and operational losses keep risk elevated. Investors should therefore treat the stock as a high‑risk, potentially undervalued play, focusing on any signs of turnaround in cash generation or debt reduction before committing capital.
Given the low price‑to‑sales multiple and the absence of dividend payments, the valuation appears discounted relative to peers, yet the balance sheet weakness and operational losses keep risk elevated. Investors should therefore treat the stock as a high‑risk, potentially undervalued play, focusing on any signs of turnaround in cash generation or debt reduction before committing capital.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- price testing support
- bearish MACD momentum
- weak cash flow
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- revenue growth continues
- analyst target upside
- high volatility may deter
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- potential balance sheet restructuring
- industry demand for graphite electrodes
- valuation discount to sales
Key Metrics & Analysis
Financial Health
Revenue Growth11.90%
Profit Margin-43.25%
P/E Ratio-1.8
ROA-4.88%
P/B Ratio-0.7
Op. Cash Flow$-64364000
Free Cash Flow$-37095000
Industry P/E31.4
Technical Analysis
TrendNeutral
RSI40.0
Support$7.50
Resistance$11.27
MA 20$8.93
MA 50$8.84
MA 200$11.59
MACDBearish
VolumeDecreasing
Fear & Greed Index91.66
Valuation
Target Price$9.25
Upside/Downside19.66%
GradeUndervalued
TypeBlend
Risk Assessment
Beta2.06
Volatility83.87%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.